中国药物警戒 ›› 2011, Vol. 8 ›› Issue (7): 410-412.

• 管理及工作研究 • 上一篇    下一篇

药品已知不良反应信息数据库构建的方法和意义

海颖   

  1. 国家食品药品监督管理局药品评价中心,北京 100045
  • 收稿日期:2011-04-29 出版日期:2011-07-10 发布日期:2015-07-13
  • 作者简介:海颖,女,硕士,医药学信息化建设。

Methods and Significance of Constructing the Database of Adverse Drug Reaction Information

HAI Ying   

  1. Center for Drug Reevaluation, SFDA, Beijing 100045, China
  • Received:2011-04-29 Online:2011-07-10 Published:2015-07-13

摘要: 目的 构建药品已知不良反应信息数据库,探讨加强和提高我国药品不良反应监测工作向科学化、规范化、透明化发展的方法和意义。方法 以约2.6万份国家食品药品监督管理局(SFDA)批准药品说明书中不良反应信息为对象,对药品说明书中不良反应数据进行了标准化、结构化的信息处理。结果 与结论 建立了对药品说明书中药品已知不良反应数据进行标准化、结构化处理的技术规范与工作流程,初步构建了一个药品已知不良反应信息数据库,对药品监测与评价及工作质量与效率起到了较好的促进和推动作用。

关键词: 药品不良反应, 药品说明书, 数据标准化, 不良反应信息数据库, 监测与评价

Abstract: Objective Construct the database of the adverse drug reaction information and explore the methods and significance which strengthen the efficiency and levels of the adverse drug reaction monitoring and promote it more legislative, more scientific and more transparent. Methods The researched objects are 26,000 pieces of package insert which were approved by SFDA. We dealed with the adverse drug reaction of the package insert in order that the information was more standardized and more structured. Results & Conclusion We obtained the criteria and procedures about constructing the database of the adverse drug reaction information and construct our database on the basis of them. That Database will actively promote and propel drug monitoring and evaluation or work quality and efficiency.

Key words: adverse drug reaction(ADR), package insert, data standardization, database of adverse drug reaction information, monitoring and evaluation

中图分类号: